EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient‐Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular Dystrophy

Vittoria Marini, Margalida Campaner Socias, Andreas Dimopoulos, Lorenza Rinvenuto, Enrico Pozzo, Diana Stalkopf, Angelo Serafini, Sara Morri, Ashley Wang, Rita La Rovere, Yoke Chin Chai, Sveva Bollini und 4 weitere

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202504004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Vittoria Marini und 15 weiteren Autor:innen. Beteiligte Einrichtung: Translational Cardiology Laboratory, Stem Cell & Developmental Biology Unit, Department of Development & Regeneration, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Organoids, Printing, Three-Dimensional, Bioprinting. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Foundation Flanders, FWO, INTERREG - Euregio Meuse-Rhine (GYM, Small Research Infrastructure KU Leuven-BioAssemblyBot.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle degeneration that significantly reduces the quality of life and lifespan of patients. Currently, cardiomyopathy represents the leading cause of death in later stages of the disease. While calcium dysregulation, fibrosis, and fat deposits are well‐documented hallmarks of DMD cardiomyopathies, the exact pathogenic mechanisms remain unclear due to the lack of reliable models. In this study, we developed 3D cardiac organoids (COs) from DMD patient‐derived induced pluripotent stem cells (DMD‐hiPSCs), their isogenic control (DMD‐Iso‐hiPSCs), and a healthy hiPSC line (HC‐hiPSCs). By day 15 of cardiac differentiation, DMD‐COs exhibited key disease features, including increased cell death, elevated ROS levels, and calcium signaling defects, compared with controls. Leveraging bioprinting technology, COs were embedded in a 7% alginate–5% gelatin hydrogel to generate bioprinted constructs (HC‐bCOs, DMD‐Iso‐bCOs, and DMD‐bCOs). These constructs self‐organized, displaying increased cell–cell communication, and reduced levels of the early cardiac transcription factor NKX2.5. By day 14 post‐bioprinting, DMD‐bCOs showed increased cell death and dysregulated expression of cardiac and fibrotic markers, mimicking DMD‐associated cardiomyopathy. This study demonstrates the potential of both COs and bCOs as a tool for studying DMD cardiomyopathy and advancing drug screening and therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneOrganoidsPrinting, Three-DimensionalBioprintingMyocardiumHumansInduced Pluripotent Stem CellsCell DifferentiationMyocytes, Cardiac

Stichwörter der Autor:innen

Duchenne muscular dystrophyalginatebioprintingcardiac organoidscardiomyopathiesgelatin

Autor:innen und Institutionen

  • Translational Cardiology Laboratory, Stem Cell & Developmental Biology Unit, Department of Development & Regeneration, KU Leuven, Leuven, Belgium.
  • Skeletal Biology and Engineering Research Centre, Department of Development & Regeneration, KU Leuven, Leuven, Belgium.
  • Prometheus - the Leuven R&D Translational Division of Skeletal Tissue Engineering, KU Leuven, Leuven, Belgium.
  • Department of Radiotherapy and Radiosurgery, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Laboratory of Molecular & Cellular Signaling, Department of Cellular & Molecular Medicine, KU Leuven, Leuven, Belgium.
  • Interuniversity Microelectronics Center (imec), Leuven, Belgium.

ORCID-Profile: Maurilio Sampaolesi

Förderung

  • Research Foundation Flanders, FWO
  • INTERREG - Euregio Meuse-Rhine (GYM
  • Small Research Infrastructure KU Leuven-BioAssemblyBot
  • ERA4Health - AmnioSMART
  • Ricerca Finalizzata from the Italian Ministry of Health
  • Medium Infrastructure KU Leuven
  • KU Leuven Research Council
  • FWO Scientific Research Network CaSign

Zitieren

APA

Marini, V., Campaner Socias, M., Dimopoulos, A., Rinvenuto, L., Pozzo, E., Stalkopf, D., Serafini, A., Morri, S., Wang, A., La Rovere, R., Chai, Y. C., Bollini, S., Bultynck, G., Roderick, H. L., Papantoniou, I., & Sampaolesi, M. (2026). Patient‐Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular Dystrophy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202504004

Vancouver

Marini V, Campaner Socias M, Dimopoulos A, Rinvenuto L, Pozzo E, Stalkopf D, et al. Patient‐Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular Dystrophy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202504004

BibTeX
@article{Marini2026,
  author = {Marini, Vittoria and Campaner Socias, Margalida and Dimopoulos, Andreas and Rinvenuto, Lorenza and Pozzo, Enrico and Stalkopf, Diana and Serafini, Angelo and Morri, Sara and Wang, Ashley and La Rovere, Rita and Chai, Yoke Chin and Bollini, Sveva and Bultynck, Geert and Roderick, H Llewelyn and Papantoniou, Ioannis and Sampaolesi, Maurilio},
  title = {Patient‐Derived 3D Bioprinted Cardiac Organoid Constructs Reveal Key Pathological Features of Duchenne Muscular Dystrophy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202504004}
}
Kostenlos starten →